| Sierra Lewellen, MSPAS, PA-C | |
|
955 Bethesda Dr Fl 1, Physician Pavilion, Zanesville, OH 43701-1873 | |
| (740) 454-0804 | |
| Not Available |
| Full Name | Sierra Lewellen |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 8 Years |
| Location | 955 Bethesda Dr Fl 1, Zanesville, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154876845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.004767RX (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Medical Group, Llc | 7719040385 | 218 |
News Archive
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study by researchers at the Stanford University School of Medicine.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
A team of anthropologists, physicians, tribal leaders and local government authorities developed and implemented a multi-phase COVID-19 prevention and containment plan among the Tsimane, an indigenous group of forager-horticulturists in the Bolivian Amazon.
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sierra Lewellen, MSPAS, PA-C 1130 Hideaway Ln, Zanesville, OH 43701-7750 Ph: () - | Sierra Lewellen, MSPAS, PA-C 955 Bethesda Dr Fl 1, Physician Pavilion, Zanesville, OH 43701-1873 Ph: (740) 454-0804 |
News Archive
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels, according to a new study by researchers at the Stanford University School of Medicine.
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase (TRK) fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
A team of anthropologists, physicians, tribal leaders and local government authorities developed and implemented a multi-phase COVID-19 prevention and containment plan among the Tsimane, an indigenous group of forager-horticulturists in the Bolivian Amazon.
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
› Verified 4 days ago
Jasmine Hessam White, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 817 Forest Ave, Zanesville, OH 43701 Phone: 740-454-7546 Fax: 740-454-6760 | |
Miss Deidra Ann Combs, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2572 Maple Ave, Zanesville, OH 43701 Phone: 833-510-4357 | |
Madeleine Marie Wirth, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 751 Forest Ave Ste 301, Zanesville, OH 43701 Phone: 740-455-4923 | |
Roni Lynn Masters, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 955 Bethesda Dr, Zanesville, OH 43701 Phone: 419-522-0320 | |
Blake Andre Smith, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2854 Bell St, Zanesville, OH 43701 Phone: 740-454-3273 Fax: 740-588-1081 | |
Ashley L Tamasovich, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 817 Forest Ave, Zanesville, OH 43701 Phone: 740-454-7546 Fax: 740-454-6760 | |
Hannah Beckett, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 945 Bethesda Dr Ste 240, Zanesville, OH 43701 Phone: 614-255-6900 Fax: 614-255-6901 |